SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-028050
Filing Date
2023-08-14
Accepted
2023-08-14 08:00:47
Documents
92
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1226565
2 ex10-4.htm EX-10.4 118362
3 ex31-1.htm EX-31.1 19307
4 ex31-2.htm EX-31.2 19169
5 ex32-1.htm EX-32.1 6522
6 ex32-2.htm EX-32.2 6218
  Complete submission text file 0001493152-23-028050.txt   6166092

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE vbiv-20230630.xsd EX-101.SCH 54938
8 XBRL CALCULATION FILE vbiv-20230630_cal.xml EX-101.CAL 71171
9 XBRL DEFINITION FILE vbiv-20230630_def.xml EX-101.DEF 200511
10 XBRL LABEL FILE vbiv-20230630_lab.xml EX-101.LAB 370403
11 XBRL PRESENTATION FILE vbiv-20230630_pre.xml EX-101.PRE 314103
86 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 841505
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 231166398
SIC: 2834 Pharmaceutical Preparations